Click here to read this item in full if you are a subscriber to this newsletter
Our Shopping Cart is currently not working; please phone us on +44 870 1657210 in working hours (08.30 to 18.00 UK time) to place your order or, at other times, please email firstname.lastname@example.org specifying the Publication, Title and Issue date of the item you require.
Issue: December 2006, page: 12
ALLOGRAFTS RETAIN IMPORTANCE - HealthPoint Capital reports on allograft market
Tissue processors are finding it difficult to meet the growing demand for allograft in spinal fusions and other orthopaedic procedures, according to a report from US private equity firm HealthPoint Capital.